BD(R) OMICS-Guard
Protects transcriptome and proteome information for up to 72 hours.
BD(R) OMICS-Guard Sample Preservation Buffer was developed to meet the needs for long-term high-quality biological sample preservation when samples cannot be processed simultaneously or in the same location. - It features a stress-free one-step preservation protocol with minimal hands-on time. - The buffer is optimized for preserving cells for various downstream transcriptome, proteome, and multi-omics applications such as RNA-seq, CITE-seq, flow cytometry, and qPCR. - It maintains cell viability and preserves various cell populations in the sample at 4°C for up to 72 hours. - It has been developed and tested across multiple sample types (PBMC and tissue samples). - Available in two user-friendly formats: 50mL bottle or 12x1mL vials.
basic information
For more details, please contact us.
Price range
Delivery Time
Applications/Examples of results
For more details, please contact us.
catalog（2）
Download All Catalogs
Recommended products
Distributors
BD Japan is the Japanese subsidiary of BD, one of the world's leading medical device and medtech companies headquartered in New Jersey, USA. BD aims to lead the world in medical technology, seeking new insights in the healthcare field and improving the quality of diagnosis and treatment, with the purpose of realizing "The future of healthcare for all(TM)." By developing innovative technologies and services related to patient treatment and healthcare processes, BD supports those working on the front lines of healthcare. With approximately 77,000 employees worldwide, BD staff support researchers in the development of next-generation diagnostic and therapeutic methods and strive daily to enhance the safety of healthcare professionals and the efficiency of medical practices in clinical settings. By partnering with healthcare institutions in countries around the world and addressing global priority issues, BD contributes to improving healthcare outcomes, reducing costs, increasing efficiency, enhancing safety, and promoting access to healthcare through close collaboration with its customers, the healthcare institutions.